Skip to content
Home/Companies/Pharma/Ardena
Ardena

Ardena

Pharma·Belgium·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Ardena?

Ardena is a Belgian Pharma company, currently owned by GHO Capital since 2020.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
GHO Capital
Investor
GHO Capital
GHO Capital Fund II LP · 2019 · Buyout

Key facts

HQBelgium
SectorPharma
StatusActive
Websiteardena.com

More from GHO Capital Fund II LP

Other portfolio companies in the same fund.

Validant
Validant
Active
Business ServicesUS· 2022
FairJourney Biologics
Exited 2024
BiotechPortugal· 2020
to Partners Group
Sterling Pharma Solutions
Active
PharmaUK· 2019

More GHO Capital portfolio companies

From the same investor, across funds.

Avid Bioservices
Avid Bioservices
Active
BiotechUS· 2025
FotoFinder Systems
FotoFinder Systems
Active
MedTechGermany· 2025
Scientist.com
Scientist.com
Active
HealthTechUS· 2025
Alcami Corporation
Alcami Corporation
Active
PharmaUS· 2022
Sanner
Sanner
Active
MedTechGermany· 2022
Sapio Sciences
Sapio Sciences
Active
HealthTechUS· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Ardena?

Ardena is currently owned by GHO Capital, through GHO Capital Fund II LP, since 2020.

When did GHO Capital acquire Ardena?

GHO Capital acquired Ardena in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue